Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118441674 | 11844167 | 4 | F | 20130416 | 20160921 | 20151217 | 20160926 | EXP | CA-ROCHE-1677280 | ROCHE | 66.01 | YR | F | Y | 0.00000 | 20160926 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118441674 | 11844167 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | Y | S0062 | 103976 | 300 | MG | SOLUTION FOR INJECTION | ||||||
| 118441674 | 11844167 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | Y | S0062 | 103976 | SOLUTION FOR INJECTION | ||||||||
| 118441674 | 11844167 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | Y | S0062 | 103976 | SOLUTION FOR INJECTION | ||||||||
| 118441674 | 11844167 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | Y | S0062 | 103976 | SOLUTION FOR INJECTION | ||||||||
| 118441674 | 11844167 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | Y | S0062 | 103976 | SOLUTION FOR INJECTION | ||||||||
| 118441674 | 11844167 | 6 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | ||||||||||||
| 118441674 | 11844167 | 7 | C | ALVESCO | CICLESONIDE | 1 | 0 | ||||||||||||
| 118441674 | 11844167 | 8 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 118441674 | 11844167 | 9 | C | OMNARIS | CICLESONIDE | 1 | 0 | ||||||||||||
| 118441674 | 11844167 | 10 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118441674 | 11844167 | 1 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118441674 | 11844167 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118441674 | 11844167 | Asthma | |
| 118441674 | 11844167 | Breath sounds abnormal | |
| 118441674 | 11844167 | Cough | |
| 118441674 | 11844167 | Drug ineffective | |
| 118441674 | 11844167 | Feeling abnormal | |
| 118441674 | 11844167 | Forced expiratory volume decreased | |
| 118441674 | 11844167 | Injection site erythema | |
| 118441674 | 11844167 | Injection site pruritus | |
| 118441674 | 11844167 | Injection site rash | |
| 118441674 | 11844167 | Injection site urticaria | |
| 118441674 | 11844167 | Ligament sprain | |
| 118441674 | 11844167 | Nasal congestion | |
| 118441674 | 11844167 | Nasopharyngitis | |
| 118441674 | 11844167 | Obstructive airways disorder | |
| 118441674 | 11844167 | Productive cough | |
| 118441674 | 11844167 | Pyrexia | |
| 118441674 | 11844167 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118441674 | 11844167 | 1 | 20121221 | 0 | ||
| 118441674 | 11844167 | 2 | 20130416 | 0 | ||
| 118441674 | 11844167 | 3 | 20130514 | 0 | ||
| 118441674 | 11844167 | 4 | 20160824 | 0 | ||
| 118441674 | 11844167 | 5 | 20160921 | 0 |